de Groot PG - Search Results

1

Platelet adhesion to subendothelial structures under flow conditions: no effect of the lipoxygenase product 13-HODE.

de Graaf JC, Bult H, de Meyer GR, Sixma JJ, de Groot PG. de Graaf JC, et al. Among authors: de groot pg, de meyer gr. Thromb Haemost. 1989 Sep 29;62(2):802-6. Thromb Haemost. 1989. PMID: 2814928

2

Impaired platelet adhesion to lysed fibrin, whereas neutrophil adhesion remains intact under conditions of flow.

Remijn JA, Da Costa Martins P, Ijsseldijk MJ, Sixma JJ, de Groot PG, Zwaginga JJ. Remijn JA, et al. Among authors: de groot pg. Blood Coagul Fibrinolysis. 2006 Jul;17(5):421-4. doi: 10.1097/01.mbc.0000233375.56723.4a. Blood Coagul Fibrinolysis. 2006. PMID: 16788321

3

Antiphospholipid antibody positive sera enhance endothelial cell procoagulant activity--studies in a thrombosis model.

Oosting JD, Derksen RH, Blokzijl L, Sixma JJ, de Groot PG. Oosting JD, et al. Among authors: de groot pg. Thromb Haemost. 1992 Sep 7;68(3):278-84. Thromb Haemost. 1992. PMID: 1440492

4

Role of plasma viscosity in platelet adhesion.

van Breugel HF, de Groot PG, Heethaar RM, Sixma JJ. van Breugel HF, et al. Among authors: de groot pg. Blood. 1992 Aug 15;80(4):953-9. Blood. 1992. PMID: 1498335 Free article.

5

In vivo experiments indicate that relatively high platelet deposition in von Willebrand's disease 'Vicenza' is caused by normal platelet-VWF levels rather than by high VWF-multimers in plasma.

d'Alessio PA, Castaman G, Rodeghiero F, de Boer HC, Federici AB, Mannucci PM, de Groot PG, Sixma JJ, Zwaginga JJ. d'Alessio PA, et al. Among authors: de groot pg, de boer hc. Thromb Res. 1992 Jan 15;65(2):221-8. doi: 10.1016/0049-3848(92)90242-3. Thromb Res. 1992. PMID: 1579897

6

Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions.

de Graaf JC, Banga JD, Moncada S, Palmer RM, de Groot PG, Sixma JJ. de Graaf JC, et al. Among authors: de groot pg. Circulation. 1992 Jun;85(6):2284-90. doi: 10.1161/01.cir.85.6.2284. Circulation. 1992. PMID: 1591842

7

Treatment of uremic anemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uremic plasma.

Zwaginga JJ, IJsseldijk MJ, de Groot PG, Kooistra M, Vos J, van Es A, Koomans HA, Struyvenberg A, Sixma JJ. Zwaginga JJ, et al. Among authors: de groot pg. Thromb Haemost. 1991 Dec 2;66(6):638-47. Thromb Haemost. 1991. PMID: 1665596 Clinical Trial.

8

Ascorbic acid increases the thrombogenicity of cellular matrices.

Hindriks GA, Sixma JJ, de Groot PG. Hindriks GA, et al. Among authors: de groot pg. Thromb Haemost. 1991 Oct 1;66(4):505-9. Thromb Haemost. 1991. PMID: 1796403

9

Platelet adhesion and aggregate formation in type I diabetes under flow conditions.

Nievelstein PF, Sixma JJ, Ottenhof-Rovers M, Wynne HJ, De Groot PG, Banga JD. Nievelstein PF, et al. Among authors: de groot pg. Diabetes. 1991 Nov;40(11):1410-7. doi: 10.2337/diab.40.11.1410. Diabetes. 1991. PMID: 1936602

10

Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma.

Zwaginga JJ, IJsseldijk MJ, de Groot PG, Vos J, de Bos Kuil RL, Sixma JJ. Zwaginga JJ, et al. Among authors: de groot pg, de bos kuil rl. Arterioscler Thromb. 1991 May-Jun;11(3):733-44. doi: 10.1161/01.atv.11.3.733. Arterioscler Thromb. 1991. PMID: 2029508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

522 results

Search Page

Filters